As of 2025-08-27, the EV/EBITDA ratio of Amryt Pharma Holdings Ltd (AMYT.L) is -27.54. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AMYT.L's latest enterprise value is 510.94 mil GBP. AMYT.L's TTM EBITDA according to its financial statements is -18.55 mil GBP. Dividing these 2 quantities gives us the above AMYT.L EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 4.1x - 12.6x | 6.6x |
| Forward P/E multiples | 5.2x - 7.9x | 6.4x |
| Fair Price | (41.07) - (52.86) | (46.72) |
| Upside | -128.7% - -137.0% | -132.7% |
| Date | EV/EBITDA |